Request Deal Involvement
Shoreline Biosciences to acquire the iNK cell franchise and gene editing technologies of Editas Medicine.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
financial advisors
Evercore
or
Principals
target
EDITAS MEDICINE (INK CELL FRANCHISE AND GENE EDITING TECHNOLOGIES)
bidder
SHORELINE BIOSCIENCES
vendor
EDITAS MEDICINE
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite